Tag: myostatin inhibitors

Pharmacologic Options for the Treatment of Sarcopenia

This 2016 review outlines pharmacologic strategies for sarcopenia, characterized by loss of muscle mass and function. While resistance exercise, protein supplementation, and vitamin D remain foundational treatments, pharmacologic options are under investigation. High-dose testosterone can increase muscle mass and strength but carries risks such as cardiovascular events and prostate enlargement.

Read More »